Works matching IS 03065251 AND DT 1992 AND VI 33 AND IP 2
1
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 203, doi. 10.1111/j.1365-2125.1992.tb04028.x
- Krivoy, N;
- Vadasz, A;
- Stoler, J;
- Jakobi, P;
- Makler, A
- Article
2
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 206, doi. 10.1111/j.1365-2125.1992.tb04030.x
- Watkins, DN;
- Badcock, NR;
- Thompson, PJ
- Article
3
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 187, doi. 10.1111/j.1365-2125.1992.tb04023.x
- Meyer, E;
- Lambert, W;
- Leenheer, A;
- Bersaques, J;
- Kint, A
- Article
4
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 143, doi. 10.1111/j.1365-2125.1992.tb04016.x
- Winstanley, PA;
- Watkins, WM;
- Newton, CR;
- Nevill, C;
- Mberu, E;
- Warn, PA;
- Waruiru, CM;
- Mwangi, IN;
- Warrell, DA;
- Marsh, K
- Article
5
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 200, doi. 10.1111/j.1365-2125.1992.tb04027.x
- Dundee, JW;
- McMillan, CM;
- Yang, J;
- Wright, PM
- Article
6
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 183, doi. 10.1111/j.1365-2125.1992.tb04022.x
- Pirmohamed, M;
- Kitteringham, NR;
- Breckenridge, AM;
- Park, BK
- Article
7
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 139, doi. 10.1111/j.1365-2125.1992.tb04015.x
- Spring, J;
- Clague, J;
- Ind, PW
- Article
8
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 197, doi. 10.1111/j.1365-2125.1992.tb04026.x
- Article
9
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 161, doi. 10.1111/j.1365-2125.1992.tb04019.x
- Gill, J;
- Fonseca, V;
- Dandona, P;
- Jeremy, JY
- Article
10
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 179, doi. 10.1111/j.1365-2125.1992.tb04021.x
- Article
11
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 129, doi. 10.1111/j.1365-2125.1992.tb04014.x
- Lipworth, BJ;
- McDevitt, DG
- Article
12
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 193, doi. 10.1111/j.1365-2125.1992.tb04025.x
- Baak, LC;
- Ganesh, S;
- Jansen, JB;
- Lamers, CB
- Article
13
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 155, doi. 10.1111/j.1365-2125.1992.tb04018.x
- Wade, JR;
- Meredith, PA;
- Hughes, DM;
- Elliott, HL
- Article
14
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 204, doi. 10.1111/j.1365-2125.1992.tb04029.x
- Lebedevs, TH;
- Wojnar-Horton, RE;
- Yapp, P;
- Roberts, MJ;
- Dusci, LJ;
- Hackett, LP;
- Ilett, KF
- Article
15
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 167, doi. 10.1111/j.1365-2125.1992.tb04020.x
- O'Neill, CJ;
- Charlett, A;
- Dobbs, RJ;
- Deshmukh, AA;
- Bowes, SG;
- Weller, C;
- Nicholson, PW;
- Milledge, JS;
- Dobbs, SM
- Article
16
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 125, doi. 10.1111/j.1365-2125.1992.tb04013.x
- Article
17
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 190, doi. 10.1111/j.1365-2125.1992.tb04024.x
- Howe, JL;
- Back, DJ;
- Colbert, J
- Article
18
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 2, p. 149, doi. 10.1111/j.1365-2125.1992.tb04017.x
- Winstanley, PA;
- Newton, CR;
- Pasvol, G;
- Kirkham, FJ;
- Mberu, E;
- Peshu, N;
- Ward, SA;
- Were, JB;
- Warrell, DA;
- Marsh, K
- Article